Using the ROR algorithm, haemoptysis (ROR 3.23, 95%CI 1.12–9.31) and acute respiratory failure (ROR 5.63, 95%CI 1.57–20.17) were mostly reported among the statistically significant reported adverse events in patients receiving PD-L1 inhibitors. Here, CD274 is linked to Hemoptysis.